Cancer anemia
Conditions
Interventions
Control group:Shengxuening tablet mimetic (sucrose plus dextrin)
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients are diagnosed as gastrointestinal tumours by imaging, pathological and/or cytological; 2. Patients meet the diagnostic criteria for mild or moderate anemia (mild anemia: Hb 90 to 120g/L or moderate anemia: Hb 60 to 90g/L), peripheral blood film shows small cell hypochromic anemia (MCV 64.44µmol/L (360µg/dl); serum ferritin (SF) <14µg/L or transferrin saturation < 0.15. 3. Aged 18 to 75 years; 4. KPS score above 70; 5. Life expecting longer than three months; 6. No chemotherapy regimen had been used before enrollment or had been discontinued for at least one month; 7. Voluntary subjects and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. With heart, liver, kidney and other important organ damage. 2. Pregnant women and mental patients. 3. With gastric cancer invading the blood vessels caused by hematemesis, blood in the stool and other major bleeding. 4. Patients did not use the drug as prescribed. 5. Any medication be used to treat anemia and improving fatigue within one month before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hb concentration;Red blood cell count;Hematocrit;Mean red blood cell volume;Red blood cell distribution width; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum iron;Total iron binding capacity;Transferrin;Serum ferritin;Karnofsky; | — |
Countries
China
Contacts
Public ContactTian Shaodan
Dongzhimen Hospital of Beijing University of traditional Chinese Medicine
Outcome results
None listed